InspireMD (NSPR) News Today $2.67 +0.10 (+3.89%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.comStockNews.com initiated coverage on shares of InspireMD in a report on Monday. They set a "sell" rating on the stock.November 18 at 3:15 AM | marketbeat.comInspireMD, Inc. (NASDAQ:NSPR) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comInspireMD Inc. Reports Q3 2024 Financial ResultsNovember 13, 2024 | markets.businessinsider.comInspireMD Inc (NSPR) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Costs and ...November 13, 2024 | finance.yahoo.comInspireMD Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 12, 2024 | markets.businessinsider.comWhat To Expect From InspireMD Inc (NSPR) Q3 2024 EarningsNovember 11, 2024 | finance.yahoo.comStockNews.com Begins Coverage on InspireMD (NYSE:NSPR)StockNews.com initiated coverage on InspireMD in a research note on Sunday. They set a "sell" rating for the company.November 10, 2024 | marketbeat.comInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)November 8, 2024 | globenewswire.comInspireMD (NSPR) Set to Announce Earnings on TuesdayInspireMD (NYSE:NSPR) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports.November 5, 2024 | marketbeat.comInspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12thNovember 4, 2024 | finance.yahoo.comInspireMD (NYSE:NSPR) Now Covered by StockNews.comStockNews.com initiated coverage on InspireMD in a research note on Saturday. They issued a "sell" rating on the stock.November 2, 2024 | marketbeat.comInspireMD (NYSE:NSPR) Coverage Initiated by Analysts at StockNews.comStockNews.com initiated coverage on InspireMD in a report on Friday. They issued a "sell" rating on the stock.October 25, 2024 | marketbeat.comOne InspireMD Insider Raised Stake By 13% In Previous YearOctober 22, 2024 | finance.yahoo.comInspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent SystemOctober 15, 2024 | globenewswire.comInspireMD Inc (NSPR) Q2 2024 Earnings Call Highlights: Navigating Growth Amidst ChallengesOctober 9, 2024 | finance.yahoo.comInspireMD (NYSE:NSPR) Research Coverage Started at StockNews.comStockNews.com initiated coverage on shares of InspireMD in a research note on Wednesday. They issued a "sell" rating for the company.October 9, 2024 | marketbeat.comInspireMD Advances with FDA Study Approval and Global GoalsOctober 8, 2024 | finance.yahoo.comInspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent SystemOctober 7, 2024 | globenewswire.comStockNews.com Initiates Coverage on InspireMD (NYSE:NSPR)StockNews.com started coverage on shares of InspireMD in a research note on Tuesday. They set a "sell" rating on the stock.October 1, 2024 | marketbeat.comInspireMD (NSPR) Receives a Buy from Piper SandlerSeptember 18, 2024 | markets.businessinsider.comInspireMD (NYSE:NSPR) Given Overweight Rating at Piper SandlerPiper Sandler reissued an "overweight" rating and set a $4.50 price objective on shares of InspireMD in a research report on Tuesday.September 17, 2024 | marketbeat.comInspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent SystemSeptember 16, 2024 | globenewswire.comInspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.comStockNews.com initiated coverage on shares of InspireMD in a research report on Sunday. They issued a "sell" rating for the company.September 15, 2024 | marketbeat.comInvestors in InspireMD (NASDAQ:NSPR) have unfortunately lost 88% over the last five yearsSeptember 14, 2024 | finance.yahoo.comInspireMD, Inc. (NSPR) Q2 2024 Earnings Call TranscriptAugust 10, 2024 | seekingalpha.comNexstar Media GAAP EPS of $3.54 misses by $0.11, revenue of $1.27B misses by $10MAugust 8, 2024 | msn.comInspireMD, Inc.: InspireMD Congratulates CREST-2 Investigators on Completion of Trial EnrollmentAugust 7, 2024 | finanznachrichten.deR1 RCM Reports Second Quarter 2024 ResultsAugust 7, 2024 | markets.businessinsider.comCompanies Like InspireMD (NASDAQ:NSPR) Are In A Position To Invest In GrowthAugust 7, 2024 | finance.yahoo.comInspireMD, Inc.: InspireMD Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 6, 2024 | finanznachrichten.deInspireMD Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 6, 2024 | finance.yahoo.comInspireMD Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 6, 2024 | globenewswire.comInspireMD Congratulates CREST-2 Investigators on Completion of Trial EnrollmentAugust 5, 2024 | globenewswire.comInspireMD (NSPR) Scheduled to Post Quarterly Earnings on TuesdayInspireMD (NYSE:NSPR) will be releasing earnings before the market opens on Tuesday, August 6, Zacks reports.July 31, 2024 | marketbeat.comInspireMD to Report Second Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, August 6thJuly 30, 2024 | globenewswire.comInspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024May 28, 2024 | globenewswire.comInspireMD (NYSE:NSPR) Announces Quarterly Earnings Results, Misses Expectations By $0.06 EPSInspireMD (NYSE:NSPR - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.21) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by ($0.06). The company had revenue of $1.51 million during the quarter, compared to the consensus estimate of $1.38 million. InspireMD had a negative net margin of 320.97% and a negative return on equity of 55.71%. During the same period in the prior year, the company posted ($0.53) EPS.May 15, 2024 | marketbeat.comInspireMD earnings preview: what Wall Street is expectingMay 15, 2024 | markets.businessinsider.comNSPR Stock Earnings: InspireMD Misses EPS, Beats Revenue for Q1 2024May 14, 2024 | investorplace.comInspireMD Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 14, 2024 | globenewswire.comInspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14thMay 7, 2024 | globenewswire.comInspireMD, Inc. (NSPR)April 26, 2024 | ca.finance.yahoo.comInspireMD to Present at the 23rd Annual Needham Virtual Healthcare ConferenceApril 3, 2024 | finance.yahoo.comInspireMD to Present at the 23rd Annual Needham Virtual Healthcare ConferenceApril 3, 2024 | globenewswire.comPope Francis appeals for Gaza cease-fire and Russia-Ukraine prisoner swap in Easter Sunday prayersMarch 31, 2024 | msn.comInspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024March 26, 2024 | globenewswire.comInspireMD (NYSE:NSPR) Releases Earnings Results, Beats Expectations By $0.04 EPSInspireMD (NYSE:NSPR - Get Free Report) issued its earnings results on Wednesday. The company reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.20) by $0.04. InspireMD had a negative net margin of 353.86% and a negative return on equity of 64.05%. During the same quarter last year, the firm earned ($0.60) EPS.March 7, 2024 | marketbeat.comInspireMD, Inc.: InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business UpdateMarch 6, 2024 | finanznachrichten.deNSPR Stock Earnings: InspireMD Beats EPS, Beats Revenue for Q4 2023March 6, 2024 | investorplace.comInspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business UpdateMarch 6, 2024 | globenewswire.com Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide NSPR Media Mentions By Week NSPR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NSPR News Sentiment▼0.870.45▲Average Medical News Sentiment NSPR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NSPR Articles This Week▼11▲NSPR Articles Average Week Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ZYXI News Today ELMD News Today LUNG News Today SKIN News Today PROF News Today SGHT News Today ZJYL News Today SONX News Today BWAY News Today DRTS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NSPR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InspireMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InspireMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
